当前位置: 首页 >> 检索结果
共有 7153 条符合本次的查询结果, 用时 5.0041996 秒

381. Reply.

作者: Mimi C Tan.;Rebecca R Richards-Kortum.;Sharmila Anandasabapathy.
来源: Gastroenterology. 2025年169卷4期749-750页

382. Can High-Resolution Microendoscopy Be Widely Adopted for Esophageal Cancer Screening in Low-Resource Settings?

作者: Yizi He.;Haiqing He.;Yongzhi Xie.
来源: Gastroenterology. 2025年169卷4期747-748页

383. Reply.

作者: Changfa Xia.;He Li.;Wanqing Chen.
来源: Gastroenterology. 2025年169卷4期746-747页

384. Presentation of the Julius M. Friedenwald Medal to David Lieberman, MD, AGAF.

作者: Sarah J Diamond.;Brian Fennerty.;David A Katzka.
来源: Gastroenterology. 2025年169卷1期165-170.e8页

385. Association between proteinuria changes and colorectal cancer incidence: evidence from a nationwide cohort study.

作者: Soo Young Oh.;Kyung-Do Han.;Ga Yoon Ku.;Won-Kyung Kang.
来源: BMC Gastroenterol. 2025年25卷1期392页
The presence of excess proteins in the urine, known as proteinuria, has been linked to various health conditions, including chronic kidney disease and cancer. Emerging evidence suggests an association between proteinuria and colorectal cancer, a leading global cause of cancer-related morbidity and mortality. However, the impact of changes in proteinuria status on colorectal cancer risk remains unclear. Understanding this relationship may identify proteinuria as a modifiable risk factor for colorectal cancer prevention.

386. Association between circadian syndrome and MASLD risk: evidence from a large cross-sectional study.

作者: Jihan Sun.;Shuqi Mao.;Caide Lu.
来源: BMC Gastroenterol. 2025年25卷1期391页
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver condition closely associated with metabolic syndrome and linked to circadian disruptions. Circadian Syndrome (CircS), a constellation of metabolic and circadian dysregulations, has emerged as a risk factor for metabolic disorders. This study aims to examine the association between CircS and MASLD and to evaluate the potential relevance of CircS in identifying individuals at elevated MASLD risk.

387. Effect of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum on the expression of genes related to colorectal cancer in colon adenocarcinoma (Caco-2) cell line.

作者: Rahimeh Maqsoodi.;Masoumeh Saberpour.;Bita Bakhshi.;Fatemeh Fallah.
来源: BMC Gastroenterol. 2025年25卷1期394页
Colorectal cancer (CRC) is emerged as a global problem with high mortality rate; hence, finding of alternative treatment approaches is essential. The purposes of this research are to assess the impact of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum (CTNP/B.b-sup) on genes associated with CRC signaling pathways.

388. The association between inflammatory biomarkers and gallstones in Americans under 50 years old.

作者: Shuqin Cheng.;Yaping Zhang.;Lu Jiang.;Jiana Li.;Runci Jiang.;Fengmei Wang.
来源: BMC Gastroenterol. 2025年25卷1期393页
This study aimed to assess the link between inflammatory biomarkers (like the neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammatory index (SII), and systemic inflammation response index (SIRI)) and gallstones in American individuals aged under 50 years.

389. Initial development and validation of a disease-specific resilience measure for inflammatory bowel disease: the RISE-IBD instrument.

作者: Michelle Mendiolaza.;Camila Vicioso.;Wamia Siddiqui.;Karan Lingineni.;Ksenia Gorbenko.;Parul Agarwal.;Laurie Keefer.
来源: BMC Gastroenterol. 2025年25卷1期390页
Inflammatory bowel diseases (IBDs) have a substantial effect on the well-being and quality of life of patients. While resilience may help alleviate psychological and physical burdens in individuals with IBD, there is no disease-specific measure that currently exists to accurately quantify this construct in the context of IBD. This study aimed to psychometrically validate the new Resilience Scale for IBD (RISE-IBD).

390. Development of Acute Kidney Injury in a Patient With Alcohol-Related Cirrhosis: The Importance of Diagnosing the Cause of Acute Kidney Injury.

作者: Adrià Juanola.;Ann T Ma.;Giuseppe Cullaro.;Mariam P Alexander.;Andrew S Allegretti.;Pere Ginès.
来源: Gastroenterology. 2025年169卷2期221-229.e1页

391. Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.

作者: Sophie Irwin.;Mieke van Daelen.;Isabella Almaraz.;Rebecca Park.;Becca Nelson.;Swapna Mahurkar-Joshi.;Florian Rieder.;David Q Shih.;Wendy Ho.;Berkeley Limketkai.;Hon Wai Koon.
来源: Gastroenterology. 2025年
About 30%-50% of patients with Crohn's disease (CD) eventually develop intestinal strictures, with intestinal fibrosis being a major component of them. There is currently no approved medication to treat fibrotic strictures.

392. Association between celiac disease and risk of kidney diseases: a systematic review and meta-analysis.

作者: Sawai S Rathore.;Shifa P Shaikh.;Hyder R Zaidi.;George O Salako.;Chiranjeevee R Saravanan.;Rabiat R Kuranga.;Narendra Yagateela.;Sai T Bandala.;Bijay M Jeswani.
来源: Minerva Gastroenterol (Torino). 2025年71卷2期96-102页
Celiac disease (CD), an autoimmune disorder, has been linked to chronic kidney disease but results are inconsistent. This meta-analysis investigates the association between CD and the risk of kidney disease.

393. Clinical efficacy of TACE using coil or gelatin sponge combined with targeted therapy in the treatment of giant hepatocellular carcinoma with arterioportal fistulas.

作者: Zhijuan Wu.;Min Zhang.;Ruirui Tian.;Jibing Liu.;Xu Chang.;Shangkun Ning.;Yingli Yu.;Lin Zhang.
来源: BMC Gastroenterol. 2025年25卷1期387页
The present study aimed to evaluate the effectiveness of spring coils or gelatin sponges for the embolization of giant hepatocellular carcinoma (HCC) with a hepatic arterioportal shunt (APS) in targeted therapy.

394. Worldwide burden and cross-regional health inequalities of high BMI-attributable colorectal cancer by gender from 1990 to 2021, with predictions through 2041.

作者: Jinhai Zhang.;Jingge Yang.
来源: BMC Gastroenterol. 2025年25卷1期386页
To analyze the worldwide, regional, and national burden and trends of colorectal cancer (CRC) attributable to high body mass index (BMI) by gender from 1990 to 2021 and to forecast the burden through 2041.

395. Better diagnostic accuracy for GERD observed with the new MNBI cutoff: an observational study in Vietnam.

作者: Hang Dao Viet.;Hue Luu Thi Minh.;Long Hoang Bao.;Phuong Do Nhat.;Long Dao Van.
来源: BMC Gastroenterol. 2025年25卷1期388页
Mean nocturnal baseline impedance (MNBI) is a novel metric for multichannel ambulatory impedance and pH (MI-pH) monitoring used to diagnose gastroesophageal reflux disease (GERD); however, its thresholds vary among different geographic areas and measuring systems. This study analyzed MI-pH data from Vietnamese patients to assess the diagnostic utility of novel MNBI thresholds in identifying GERD.

396. Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study.

作者: Øystein K Moe.;Qian Gao.;Dawei Geng.;Einar Jensen.;Rasmus Goll.;Oddmund Nestegard.;Mona D Gundersen.;Jon R Florholmen.;T Moritz.
来源: BMC Gastroenterol. 2025年25卷1期389页
Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough-levels.

397. To verify the biological characteristics of disulfidptosis associated gene ADORA2B in esophageal cancer.

作者: Yixiao Cui.;Yuhan Deng.;Zhenhua Wu.;Xiaohong Sun.
来源: BMC Gastroenterol. 2025年25卷1期382页
Esophageal cancer is an aggressive malignant tumor. Statistics show that esophageal cancer has claimed the lives of approximately 300,000 people worldwide. Many patients are diagnosed as stage 3 or 4 when they visit a doctor; however, the prognosis may not be accurate because the disease's early signs are not always evident. The gene ADORA2B may be important in the diagnosis and prognosis of esophageal cancer, as adenosine (ADO) is implicated in the proliferation and spread of many malignancies. Through the use of bioinformatics analysis, this study sought to discover and validate particular genes and putative pathways linked to the course and prognosis of esophageal cancer. Utilizing integrated transcriptomics and single-cell proteomics, the involvement of immune cells in the tumor microenvironment was examined, while bioinformatics was used to investigate the expression, function, and survival data of ADORA2B. Western blot (WB) and qRT-PCR were then used to determine the expression level of ADORA2B in the postoperative tissues of patients with esophageal cancer. Tests using Transwell, Edu, and CCK8 were performed to ascertain its capacity for erosion, migration, invasion, and proliferation. Flow cytometry was used to quantify apoptosis. The results of this investigation validate ADORA2B as a potential therapeutic target and diagnostic biomarker.

398. Sphincter-saving surgery for failed organ preservation after a neoadjuvant therapy and radiation boost: A surgeon's perspective.

作者: Sanjay Singh.;Abdeali Saif Arif Kaderi.;Mufaddal Kazi.;Ashwin Desouza.;Ankit Sharma.;Suman Kumar Ankathi.;Avanish Saklani.
来源: BMC Gastroenterol. 2025年25卷1期384页
This study investigates the functional outcomes of patients with low rectal cancer undergoing inter-sphincteric resection (ISR) following brachytherapy boost radiotherapy (BoRT), compared to those who underwent ISR after standard chemoradiotherapy. BoRT is an alternative to total neoadjuvant therapy for increasing organ preservation rates in low rectal cancers. However, its impact on sphincter function following stoma reversal remains unclear.

399. Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats.

作者: Masaya Okada.;Masakazu Hanayama.;Yasunori Yamamoto.;Teruki Miyake.;Osamu Yoshida.;Eiji Takeshita.;Yoshio Ikeda.;Yoichi Hiasa.
来源: BMC Gastroenterol. 2025年25卷1期385页
Pemafibrate helps regulate fatty acid dynamics in the liver, potentially preventing metabolic dysfunction-associated steatohepatitis (MASH). However, its effect on intestinal long-chain fatty acid (LCFA) metabolism in MASH remains unclear. Thus, we aimed to examine the influence of pemafibrate on intestinal LCFA metabolism and hepatic fibrosis in a MASH rat model.

400. The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients.

作者: Fatemeh Dayyan.;Farhad Zamani.;Hossein Ajdarkosh.;Mahmoodreza Khoonsari.;Amirhossein Faraji.;Mehdi Nikkhah.;Akram Nourian.;Fahimeh Safarnezhad Tameshkel.;Elham Sobhrakhshankhah.
来源: BMC Gastroenterol. 2025年25卷1期383页
Cholangiocarcinoma (CCA) has a low survival rate of 5-17%, despite advancements in diagnosis and treatment. Liver function impacts disease prognosis, and the albumin-bilirubin (ALBI) score is a new assessment model for this purpose. While research suggests a correlation between ALBI score, liver failure and mortality in intrahepatic CCA (iCCA), predicting outcomes for extrahepatic CCA (eCCA) is challenging. Our objective was to assess the prognostic role of ALBI grade in predicting overall survival of eCCA patients.
共有 7153 条符合本次的查询结果, 用时 5.0041996 秒